Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 2 of the last 4 fiscal years.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Tight liquidity NBB
Cash and receivables cover 22 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
EURAMAC-PHARMACH from De Panne, company number BE0597865537, closed financial year 2025 with a result of € -25,287 after tax. For that financial year EURAMAC-PHARMACH recorded a gross margin of € -19,945 and equity of € -28,304. Compared with financial year 2024, the result moved from € -30,463 to € -25,287. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on May 22, 2026.
€ -28,304
▼ € 25,287 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -25,287
▲ 17 % less loss than in 2024
Profit after tax over the fiscal year.
€ 1,382
▼ 62% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -46,904.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 337
▼ 88% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 177
▼ 51% vs 2024
Loans from banks and other lenders, long and short.
€ 2,164
▲ € 1,651 vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 3,137
▼ 39% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 22,350 | € -1,156 | € -16,525 | € -19,945 | ▼ € 3,420 |
| Profit after taxes | € 5,925 | € -12,285 | € -30,463 | € -25,287 | ▲ € 5,175 |
| Equity | € 39,731 | € 27,446 | € -3,017 | € -28,304 | ▼ € 25,287 |
| Total debts | € 23,481 | € 17,060 | € 16,527 | € 38,456 | ▲ 133% |
| Cash | € 709 | € 3,395 | € 3,616 | € 1,382 | ▼ 62% |
| Retained profit | € 21,131 | € 8,846 | € -21,617 | € -46,904 | ▼ € 25,287 |
| Bank debt | € 9,069 | € 3,591 | € 358 | € 177 | ▼ 51% |
| Balance sheet total | € 63,212 | € 44,506 | € 13,511 | € 10,152 | ▼ 25% |
Key figures of EURAMAC-PHARMACH, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to EURAMAC-PHARMACH?
What happened at EURAMAC-PHARMACH in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 25,287. Source: NBB ↗
- JEAN CLAERHOUT became a director. NBB
- New establishment in De Panne. KBO
- Start of the company according to the CBE. KBO
In short
From € 5,925 profit in 2022 to € 25,287 loss in 2025.
Paid € 5,234 in corporate taxes since 2022.
Best year ever: 2022, with € 5,925 profit.
A new publication or filing at EURAMAC-PHARMACH? We notify you, reason included.
Follow EURAMAC-PHARMACHDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind EURAMAC-PHARMACH is JEAN CLAERHOUT. JEAN CLAERHOUT is also behind Pharmach.
Directors
According to the 2025 annual accounts
since 2020
Establishments
Establishment units
Physical locations of this company
Nieuwpoortlaan 34
8660 De Panne
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0597.865.537
- VAT number
- BE 0597.865.537
- Registered office
- Nieuwpoortlaan 34, 8660 De Panne
- Names & denominations
- EURAMAC-PHARMACH
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 11 February 2015
- Peppol
- Active · Active since 26 Feb 2025
- Activities · NACE
Groothandel in machines voor de mijnbouw, de bouwnijverheid en de weg- en waterbouw
Computerinfrastructuur, gegevensverwerking, hosting en aanverwante activiteiten
Overige diensten op het gebied van informatietechnologie en computer
Ontwikkeling van niet-residentiële bouwprojecten
Ontwerpen van computerprogramma’s
Handelsbemiddeling in de niet-gespecialiseerde groothandel
Activiteiten op het gebied van computerconsultancy en beheer van computerfaciliteiten
Beheer van computerfaciliteiten
+3